Compendium of Cancer Genome Aberrations

MALE5:Volunteer Assignments and Opportunities: Difference between revisions

[checked revision][checked revision]
VisualWikitext
Created page with "Welcome! For assignments, please see the "Author" column below (highlighted blue). If empty (no name is present), please volunteer to create content for that disease! To vo..."
 
No edit summary
 
(6 intermediate revisions by the same user not shown)
Line 6: Line 6:


To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.
To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.
__TOC__
{| class="wikitable" style="margin:auto"
{| class="wikitable" style="margin:auto"
|+<big>WHO Classification of Urinary and Male Genital Tumours (5th Edition) Content</big>
|+<big>WHO Classification of Urinary and Male Genital Tumours (5th Edition) Content</big>
Line 17: Line 19:
!'''Notes'''
!'''Notes'''
|-
|-
|
==== CHAPTER 2 (TUMOURS OF THE KIDNEY) ====
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|-
|[[MALE5:Clear_cell_renal_cell_carcinoma|Clear cell renal cell carcinoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:Multilocular_cystic_renal_neoplasm_of_low_malignant_potential|Multilocular cystic renal neoplasm of low malignant potential]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:Renal_papillary_adenoma|Renal papillary adenoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:Papillary_renal_cell_carcinoma|Papillary renal cell carcinoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:Oncocytoma_of_the_kidney|Oncocytoma of the kidney]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:Chromophobe_renal_cell_carcinoma|Chromophobe renal cell carcinoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:Other_oncocytic_tumours_of_the_kidney|Other oncocytic tumours of the kidney]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:Collecting_duct_carcinoma|Collecting duct carcinoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:Clear_cell_papillary_renal_cell_tumour|Clear cell papillary renal cell tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:Mucinous_tubular_and_spindle_cell_carcinoma|Mucinous tubular and spindle cell carcinoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:Tubulocystic_renal_cell_carcinoma|Tubulocystic renal cell carcinoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:Acquired_cystic_disease-associated_renal_cell_carcinoma|Acquired cystic disease-associated renal cell carcinoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:Eosinophilic_solid_and_cystic_renal_cell_carcinoma|Eosinophilic solid and cystic renal cell carcinoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:Renal_cell_carcinoma_NOS|Renal cell carcinoma NOS]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:TFE3-rearranged_renal_cell_carcinomas|TFE3-rearranged renal cell carcinomas]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:TFEB-altered_renal_cell_carcinomas|TFEB-altered renal cell carcinomas]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:ELOC_(formerly_TCEB1)-mutated_renal_cell_carcinoma|ELOC (formerly TCEB1)-mutated renal cell carcinoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:Fumarate_hydratase-deficient_renal_cell_carcinoma|Fumarate hydratase-deficient renal cell carcinoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:Succinate_dehydrogenase-deficient_renal_cell_carcinoma|Succinate dehydrogenase-deficient renal cell carcinoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:ALK-rearranged_renal_cell_carcinomas|ALK-rearranged renal cell carcinomas]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:SMARCB1-deficient_renal_medullary_carcinoma|SMARCB1-deficient renal medullary carcinoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:Metanephric_adenoma|Metanephric adenoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:Metanephric_adenofibroma|Metanephric adenofibroma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:Metanephric_stromal_tumour|Metanephric stromal tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:Mixed_epithelial_and_stromal_tumour_of_the_kidney|Mixed epithelial and stromal tumour of the kidney]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:Paediatric_cystic_nephroma|Paediatric cystic nephroma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:Classic_angiomyolipoma_/_PEComa_of_the_kidney|Classic angiomyolipoma / PEComa of the kidney]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:Epithelioid_angiomyolipoma_/_epithelioid_PEComa_of_the_kidney|Epithelioid angiomyolipoma / epithelioid PEComa of the kidney]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:Renal_haemangioblastoma|Renal haemangioblastoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:Juxtaglomerular_cell_tumour|Juxtaglomerular cell tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:Renomedullary_interstitial_cell_tumour|Renomedullary interstitial cell tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:Ossifying_renal_tumour_of_infancy|Ossifying renal tumour of infancy]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:Congenital_mesoblastic_nephroma|Congenital mesoblastic nephroma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:Rhabdoid_tumour_of_the_kidney|Rhabdoid tumour of the kidney]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:Clear_cell_sarcoma_of_the_kidney|Clear cell sarcoma of the kidney]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:Nephrogenic_rests_|Nephrogenic rests]]
|Disease
|
|
|
|
|
|
|
|
|-
|-
| ||Disease||
|[[MALE5:Cystic_partially_differentiated_nephroblastoma|Cystic partially differentiated nephroblastoma]]
|Disease
|
|
|
|
|
Line 27: Line 447:
|
|
|-
|-
| ||Disease||
|[[MALE5:Nephroblastoma|Nephroblastoma]]
|Disease
|
|
|
|
|
Line 36: Line 458:
|
|
|-
|-
| ||Disease||
|[[MALE5:Germ_cell_tumours_of_the_kidney|Germ cell tumours of the kidney]]
|Disease
|
|
|
|
|
Line 45: Line 469:
|
|
|-
|-
| ||Disease||
|
|
==== CHAPTER 3 (TUMOURS OF THE URINARY TRACT) ====
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
----
|
----
|
----
|-
|-
| ||Disease||
|[[MALE5:Urothelial_papilloma|Urothelial papilloma]]
|Disease
|
|
|
|
|
Line 63: Line 501:
|
|
|-
|-
| ||Disease||
|[[MALE5:Inverted_urothelial_papilloma|Inverted urothelial papilloma]]
|Disease
|
|
|
|
|
Line 72: Line 512:
|
|
|-
|-
| ||Disease||
|[[MALE5:Papillary_urothelial_neoplasm_of_low_malignant_potential|Papillary urothelial neoplasm of low malignant potential]]
|Disease
|
|
|
|
|
Line 81: Line 523:
|
|
|-
|-
| ||Disease||
|[[MALE5:Non-invasive_papillary_urothelial_carcinoma,_low-grade|Non-invasive papillary urothelial carcinoma, low-grade]]
|Disease
|
|
|
|
|
Line 90: Line 534:
|
|
|-
|-
| ||Disease||
|[[MALE5:Non-invasive_papillary_urothelial_carcinoma,_high-grade|Non-invasive papillary urothelial carcinoma, high-grade]]
|Disease
|
|
|
|
|
Line 99: Line 545:
|
|
|-
|-
| ||Disease||
|[[MALE5:Urothelial_carcinoma_in_situ|Urothelial carcinoma in situ]]
|Disease
|
|
|
|
|
Line 108: Line 556:
|
|
|-
|-
| ||Disease||
|[[MALE5:Invasive_urothelial_carcinoma|Invasive urothelial carcinoma]]
|Disease
|
|
|
|
|
Line 117: Line 567:
|
|
|-
|-
| ||Disease||
|[[MALE5:Squamous_papilloma_of_the_urothelial_tract|Squamous papilloma of the urothelial tract]]
|Disease
|
|
|
|
|
Line 126: Line 578:
|
|
|-
|-
| ||Disease||
|[[MALE5:Verrucous_carcinoma_of_the_bladder|Verrucous carcinoma of the bladder]]
|Disease
|
|
|
|
|
Line 135: Line 589:
|
|
|-
|-
| ||Disease||
|[[MALE5:Pure_squamous_carcinoma_of_the_urothelial_tract|Pure squamous carcinoma of the urothelial tract]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:Villous_adenoma|Villous adenoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:Adenocarcinoma_NOS|Adenocarcinoma NOS]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:Urachal_carcinoma|Urachal carcinoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:Diverticular_carcinoma|Diverticular carcinoma]]
|Disease
|
|
|
|
|
Line 144: Line 644:
|
|
|-
|-
| ||Disease||
|[[MALE5:Littre_gland_adenocarcinoma_of_the_urethra|Littre gland adenocarcinoma of the urethra]]
|Disease
|
|
|
|
|
Line 153: Line 655:
|
|
|-
|-
| ||Disease||
|[[MALE5:Skene_gland_adenocarcinoma_of_the_urethra|Skene gland adenocarcinoma of the urethra]]
|Disease
|
|
|
|
|
Line 162: Line 666:
|
|
|-
|-
| ||Disease||
|[[MALE5:Cowper_gland_adenocarcinoma_of_the_urethra|Cowper gland adenocarcinoma of the urethra]]
|Disease
|
|
|
|
|
Line 171: Line 677:
|
|
|-
|-
| ||Disease||
|[[MALE5:Clear_cell_adenocarcinoma_of_the_urinary_tract|Clear cell adenocarcinoma of the urinary tract]]
|Disease
|
|
|
|
|
Line 180: Line 688:
|
|
|-
|-
| ||Disease||
|[[MALE5:Endometrioid_carcinoma_of_the_urinary_tract|Endometrioid carcinoma of the urinary tract]]
|Disease
|
|
|
|
|
Line 189: Line 699:
|
|
|-
|-
| ||Disease||
|
|
==== CHAPTER 4 (TUMOURS OF THE PROSTATE) ====
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
----
|
----
|
----
|-
|-
| ||Disease||
|[[MALE5:Prostatic_cystadenoma|Prostatic cystadenoma]]
|Disease
|
|
|
|
|
Line 207: Line 731:
|
|
|-
|-
| ||Disease||
|[[MALE5:High-grade_prostatic_intraepithelial_neoplasia|High-grade prostatic intraepithelial neoplasia]]
|Disease
|
|
|
|
|
Line 216: Line 742:
|
|
|-
|-
| ||Disease||
|[[MALE5:Intraductal_carcinoma_of_the_prostate|Intraductal carcinoma of the prostate]]
|Disease
|
|
|
|
|
Line 225: Line 753:
|
|
|-
|-
| ||Disease||
|[[MALE5:Prostatic_acinar_adenocarcinoma|Prostatic acinar adenocarcinoma]]
|Disease
|
|
|
|
|
Line 234: Line 764:
|
|
|-
|-
| ||Disease||
|[[MALE5:Prostatic_ductal_adenocarcinoma|Prostatic ductal adenocarcinoma]]
|Disease
|
|
|
|
|
Line 243: Line 775:
|
|
|-
|-
| ||Disease||
|[[MALE5:Treatment-related_neuroendocrine_prostatic_carcinoma|Treatment-related neuroendocrine prostatic carcinoma]]
|Disease
|
|
|
|
|
Line 252: Line 786:
|
|
|-
|-
| ||Disease||
|[[MALE5:_Adenosquamous_carcinoma_of_the_prostate| Adenosquamous carcinoma of the prostate]]
|Disease
|
|
|
|
|
Line 261: Line 797:
|
|
|-
|-
| ||Disease||
|[[MALE5:_Squamous_cell_carcinoma_of_the_prostate| Squamous cell carcinoma of the prostate]]
|Disease
|
|
|
|
|
Line 270: Line 808:
|
|
|-
|-
| ||Disease||
|[[MALE5:_Adenoid_cystic_(basal_cell)_carcinoma_of_the_prostate| Adenoid cystic (basal cell) carcinoma of the prostate]]
|Disease
|
|
|
|
|
Line 279: Line 819:
|
|
|-
|-
| ||Disease||
|[[MALE5:Prostatic_stromal_tumour_of_uncertain_malignant_potential|Prostatic stromal tumour of uncertain malignant potential]]
|Disease
|
|
|
|
|
Line 288: Line 830:
|
|
|-
|-
| ||Disease||
|[[MALE5:Prostatic_stromal_sarcoma|Prostatic stromal sarcoma]]
|Disease
|
|
|
|
|
Line 297: Line 841:
|
|
|-
|-
| ||Disease||
|
|
==== CHAPTER 5 (TUMOURS OF THE SIMINAL VESICLE) ====
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
----
|
----
|
----
|-
|-
| ||Disease||
|[[MALE5:Cystadenoma_of_the_seminal_vesicle|Cystadenoma of the seminal vesicle]]
|Disease
|
|
|
|
|
Line 315: Line 873:
|
|
|-
|-
| ||Disease||
|[[MALE5:Adenocarcinoma_of_the_seminal_vesicle|Adenocarcinoma of the seminal vesicle]]
|Disease
|
|
|
|
|
Line 324: Line 884:
|
|
|-
|-
| ||Disease||
|[[MALE5:Squamous_cell_carcinoma_of_the_seminal_vesicle|Squamous cell carcinoma of the seminal vesicle]]
|Disease
|
|
|
|
|
Line 333: Line 895:
|
|
|-
|-
| ||Disease||
|[[MALE5:Mixed_epithelial_and_stromal_tumour_of_the_seminal_vesicle|Mixed epithelial and stromal tumour of the seminal vesicle]]
|Disease
|
|
|
|
|
Line 342: Line 906:
|
|
|-
|-
| ||Disease||
|
|
==== CHAPTER 6 (TUMOURS OF THE TESTIS) ====
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
----
|
----
|
----
|-
|-
| ||Disease||
|[[MALE5:_Germ_cell_neoplasia_in_situ| Germ cell neoplasia in situ]]
|Disease
|
|
|
|
|
Line 360: Line 938:
|
|
|-
|-
| ||Disease||
|[[MALE5:_Specific_forms_of_intratubular_germ_cell_neoplasia| Specific forms of intratubular germ cell neoplasia]]
|Disease
|
|
|
|
|
Line 369: Line 949:
|
|
|-
|-
| ||Disease||
|[[MALE5:_Gonadoblastoma| Gonadoblastoma]]
|Disease
|
|
|
|
|
Line 378: Line 960:
|
|
|-
|-
| ||Disease||
|[[MALE5:_Seminoma| Seminoma]]
|Disease
|
|
|
|
|
Line 387: Line 971:
|
|
|-
|-
| ||Disease||
|[[MALE5:_Embryonal_carcinoma| Embryonal carcinoma]]
|Disease
|
|
|
|
|
Line 396: Line 982:
|
|
|-
|-
| ||Disease||
|[[MALE5:_Yolk_sac_tumour,_postpubertal-type| Yolk sac tumour, postpubertal-type]]
|Disease
|
|
|
|
|
Line 405: Line 993:
|
|
|-
|-
| ||Disease||
|[[MALE5:_Choriocarcinoma| Choriocarcinoma]]
|Disease
|
|
|
|
|
Line 414: Line 1,004:
|
|
|-
|-
| ||Disease||
|[[MALE5:_Placental_site_trophoblastic_tumour| Placental site trophoblastic tumour]]
|Disease
|
|
|
|
|
Line 423: Line 1,015:
|
|
|-
|-
| ||Disease||
|[[MALE5:_Epithelioid_trophoblastic_tumour| Epithelioid trophoblastic tumour]]
|Disease
|
|
|
|
|
Line 432: Line 1,026:
|
|
|-
|-
| ||Disease||
|[[MALE5:_Cystic_trophoblastic_tumour| Cystic trophoblastic tumour]]
|Disease
|
|
|
|
|
Line 441: Line 1,037:
|
|
|-
|-
| ||Disease||
|[[MALE5:Teratoma,_postpubertal-type|Teratoma, postpubertal-type]]
|Disease
|
|
|
|
|
Line 450: Line 1,048:
|
|
|-
|-
| ||Disease||
|[[MALE5:Teratoma_with_somatic-type_malignancy|Teratoma with somatic-type malignancy]]
|Disease
|
|
|
|
|
Line 459: Line 1,059:
|
|
|-
|-
| ||Disease||
|[[MALE5:_Mixed_germ_cell_tumours| Mixed germ cell tumours]]
|Disease
|
|
|
|
|
Line 468: Line 1,070:
|
|
|-
|-
| ||Disease||
|[[MALE5:_Regressed_germ_cell_tumours| Regressed germ cell tumours]]
|Disease
|
|
|
|
|
Line 477: Line 1,081:
|
|
|-
|-
| ||Disease||
|[[MALE5:Spermatocytic_tumour|Spermatocytic tumour]]
|Disease
|
|
|
|
|
Line 486: Line 1,092:
|
|
|-
|-
| ||Disease||
|[[MALE5:_Teratoma,_prepubertal-type| Teratoma, prepubertal-type]]
|Disease
|
|
|
|
|
Line 495: Line 1,103:
|
|
|-
|-
| ||Disease||
|[[MALE5:Yolk_sac_tumour,_prepubertal-type|Yolk sac tumour, prepubertal-type]]
|Disease
|
|
|
|
|
Line 504: Line 1,114:
|
|
|-
|-
| ||Disease||
|[[MALE5:Testicular_neuroendocrine_tumour,_prepubertal-type|Testicular neuroendocrine tumour, prepubertal-type]]
|Disease
|
|
|
|
|
Line 513: Line 1,125:
|
|
|-
|-
| ||Disease||
|[[MALE5:Mixed_teratoma_and_yolk_sac_tumour,_prepubertal-type|Mixed teratoma and yolk sac tumour, prepubertal-type]]
|Disease
|
|
|
|
|
Line 522: Line 1,136:
|
|
|-
|-
| ||Disease||
|[[MALE5:_Leydig_cell_tumour| Leydig cell tumour]]
|Disease
|
|
|
|
|
Line 531: Line 1,147:
|
|
|-
|-
| ||Disease||
|[[MALE5:_Sertoli_cell_tumour| Sertoli cell tumour]]
|Disease
|
|
|
|
|
Line 540: Line 1,158:
|
|
|-
|-
| ||Disease||
|[[MALE5:Large_cell_calcifying_Sertoli_cell_tumour|Large cell calcifying Sertoli cell tumour]]
|Disease
|
|
|
|
|
Line 549: Line 1,169:
|
|
|-
|-
| ||Disease||
|[[MALE5:_Adult_granulosa_cell_tumour| Adult granulosa cell tumour]]
|Disease
|
|
|
|
|
Line 558: Line 1,180:
|
|
|-
|-
| ||Disease||
|[[MALE5:_Juvenile_granulosa_cell_tumour| Juvenile granulosa cell tumour]]
|Disease
|
|
|
|
|
Line 567: Line 1,191:
|
|
|-
|-
| ||Disease||
|[[MALE5:_Tumours_in_the_fibroma_thecoma_group| Tumours in the fibroma thecoma group]]
|Disease
|
|
|
|
|
Line 576: Line 1,202:
|
|
|-
|-
| ||Disease||
|[[MALE5:Mixed_sex_cord_stromal_tumour|Mixed sex cord stromal tumour]]
|Disease
|
|
|
|
|
Line 585: Line 1,213:
|
|
|-
|-
| ||Disease||
|[[MALE5:Signet_ring_stromal_tumour|Signet ring stromal tumour]]
|Disease
|
|
|
|
|
Line 594: Line 1,224:
|
|
|-
|-
| ||Disease||
|[[MALE5:Myoid_gonadal_stromal_tumour|Myoid gonadal stromal tumour]]
|Disease
|
|
|
|
|
Line 603: Line 1,235:
|
|
|-
|-
| ||Disease||
|[[MALE5:Sex_cord_stromal_tumour_NOS|Sex cord stromal tumour NOS]]
|Disease
|
|
|
|
|
Line 612: Line 1,246:
|
|
|-
|-
| ||Disease||
|
|
==== CHAPTER 7 (TUMOURS OF THE TESTICULAR ADNEXA) ====
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
----
|
----
|-
|-
| ||Disease||
|[[MALE5:_Serous_cystadenoma| Serous cystadenoma]]
|Disease
|
|
|
|
|
Line 630: Line 1,278:
|
|
|-
|-
| ||Disease||
|[[MALE5:_Serous_tumour_of_borderline_malignancy| Serous tumour of borderline malignancy]]
|Disease
|
|
|
|
|
Line 639: Line 1,289:
|
|
|-
|-
| ||Disease||
|[[MALE5:_Serous_cystadenocarcinoma| Serous cystadenocarcinoma]]
|Disease
|
|
|
|
|
Line 648: Line 1,300:
|
|
|-
|-
| ||Disease||
|[[MALE5:_Mucinous_cystadenoma| Mucinous cystadenoma]]
|Disease
|
|
|
|
|
Line 657: Line 1,311:
|
|
|-
|-
| ||Disease||
|[[MALE5:_Mucinous_borderline_tumour| Mucinous borderline tumour]]
|Disease
|
|
|
|
|
Line 666: Line 1,322:
|
|
|-
|-
| ||Disease||
|[[MALE5:_Mucinous_cystadenocarcinoma| Mucinous cystadenocarcinoma]]
|Disease
|
|
|
|
|
Line 675: Line 1,333:
|
|
|-
|-
| ||Disease||
|[[MALE5:_Endometrioid_tumours| Endometrioid tumours]]
|Disease
|
|
|
|
|
Line 684: Line 1,344:
|
|
|-
|-
| ||Disease||
|[[MALE5:_Clear_cell_adenocarcinoma| Clear cell adenocarcinoma]]
|Disease
|
|
|
|
|
Line 693: Line 1,355:
|
|
|-
|-
| ||Disease||
|[[MALE5:_Brenner_tumour| Brenner tumour]]
|Disease
|
|
|
|
|
Line 702: Line 1,366:
|
|
|-
|-
| ||Disease||
|[[MALE5:Adenoma_of_the_collecting_ducts_and_rete_testis|Adenoma of the collecting ducts and rete testis]]
|Disease
|
|
|
|
|
Line 711: Line 1,377:
|
|
|-
|-
| ||Disease||
|[[MALE5:Adenocarcinoma_of_the_collecting_ducts_and_rete_testis|Adenocarcinoma of the collecting ducts and rete testis]]
|Disease
|
|
|
|
|
Line 720: Line 1,388:
|
|
|-
|-
| ||Disease||
|[[MALE5:_Adenomatoid_tumour| Adenomatoid tumour]]
|Disease
|
|
|
|
|
Line 729: Line 1,399:
|
|
|-
|-
| ||Disease||
|[[MALE5:_Well-differentiated_papillary_mesothelial_tumour| Well-differentiated papillary mesothelial tumour]]
|Disease
|
|
|
|
|
Line 738: Line 1,410:
|
|
|-
|-
|[[MALE5:_Mesothelioma| Mesothelioma]]
|Disease
|
|
|
|
|
|
|
|
|
|-
|[[MALE5:_Cystadenoma_of_the_epididymis| Cystadenoma of the epididymis]]
|Disease
|Disease
|
|
Line 748: Line 1,431:
|
|
|
|
|-
|[[MALE5:_Papillary_cystadenoma_of_the_epididymis| Papillary cystadenoma of the epididymis]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:_Adenocarcinoma_of_the_epididymis| Adenocarcinoma of the epididymis]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:Squamous_cell_carcinoma_of_the_epididymis|Squamous cell carcinoma of the epididymis]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:_Melanotic_neuroectodermal_tumour_of_the_epididymis| Melanotic neuroectodermal tumour of the epididymis]]
|Disease
|
|
|
|
|
|
|
|
|-
|
==== CHAPTER 8 (TUMOURS OF THE PENIS AND SCROTUM) ====
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|-
|[[MALE5:Condyloma_acuminatum|Condyloma acuminatum]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:Penile_intraepithelial_neoplasia,_HPV-associated|Penile intraepithelial neoplasia, HPV-associated]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:Differentiated_penile_intraepithelial_neoplasia,_HPV-independent|Differentiated penile intraepithelial neoplasia, HPV-independent]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:HPV-associated_squamous_cell_carcinoma|HPV-associated squamous cell carcinoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:HPV-independent_squamous_cell_carcinoma|HPV-independent squamous cell carcinoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:_Squamous_cell_carcinoma_NOS| Squamous cell carcinoma NOS]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:_Penile_adenosquamous_and_mucoepidermoid_carcinomas| Penile adenosquamous and mucoepidermoid carcinomas]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:Extramammary_Paget_disease|Extramammary Paget disease]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:Basal_cell_carcinoma_of_the_scrotum|Basal cell carcinoma of the scrotum]]
|Disease
|
|
|
|
|
|
|
|
|-
|
==== CHAPTER 9 (NEUROENDOCRINE NEOPLASMS) ====
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|-
|[[MALE5:Well-differentiated_neuroendocrine_tumour|Well-differentiated neuroendocrine tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:Small_cell_neuroendocrine_carcinoma|Small cell neuroendocrine carcinoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:Large_cell_neuroendocrine_carcinoma|Large cell neuroendocrine carcinoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:Mixed_neuroendocrine_neoplasms|Mixed neuroendocrine neoplasms]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:Paraganglioma|Paraganglioma]]
|Disease
|
|
|
|
|
|
|
|
|-
|
==== CHAPTER 10 (MESENCHYMAL TUMOURS) ====
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|-
|[[MALE5:The_angiofibroma_family_of_tumours|The angiofibroma family of tumours]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:Solitary_fibrous_tumour|Solitary fibrous tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:Inflammatory_myofibroblastic_tumour|Inflammatory myofibroblastic tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:Haemangioma|Haemangioma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:Angiosarcoma|Angiosarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:Glomus_tumour|Glomus tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:Myointimoma|Myointimoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:Myopericytoma|Myopericytoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:Extrarenal_PEComa|Extrarenal PEComa]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:Leiomyoma|Leiomyoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:Leiomyosarcoma|Leiomyosarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:Rhabdomyosarcoma|Rhabdomyosarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:Synovial_sarcoma|Synovial sarcoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:Extrarenal_rhabdoid_tumour|Extrarenal rhabdoid tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:Desmoplastic_small_round_cell_tumour|Desmoplastic small round cell tumour]]
|Disease
|
|
|
|
|
|
|
|
|-
|
==== CHAPTER 11 (HAEMATOLYMPHOID TUMOURS) ====
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|-
|[[MALE5:Extranodal_marginal_zone_lymphoma_of_MALT|Extranodal marginal zone lymphoma of MALT]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:Diffuse_large_B-cell_lymphoma|Diffuse large B-cell lymphoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:Plasmacytoma|Plasmacytoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:_Juvenile_xanthogranuloma| Juvenile xanthogranuloma]]
|Disease
|
|
|
|
|
|
|
|
|-
|
==== CHAPTER 12 (MELANOCYTIC LESIONS) ====
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|-
|[[MALE5:Mucosal_melanoma|Mucosal melanoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|
==== CHAPTER 13 (METASTASES IN THE GENITOURINARY SYSTEM) ====
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|-
|[[MALE5:Metastasis_to_the_urinary_tract|Metastasis to the urinary tract]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:Metastasis_to_the_kidney|Metastasis to the kidney]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:Metastasis_to_the_testis_and_paratestis|Metastasis to the testis and paratestis]]
|Disease
|
|
|
|
|
|
|
|
|-
|
==== CHAPTER 14 (GENETIC TUMOUR SYNDROMES OF TEH URINARY AND MALE GENITAL TRACTS) ====
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|-
|[[MALE5:Von_Hippel-Lindau_syndrome|Von Hippel-Lindau syndrome]]
|Disease
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|-
|[[MALE5:Birt-Hogg-Dube_syndrome|Birt-Hogg-Dube syndrome]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:Hereditary_papillary_renal_carcinoma|Hereditary papillary renal carcinoma]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:Hereditary_leiomyomatosis_and_renal_cell_carcinoma_syndrome|Hereditary leiomyomatosis and renal cell carcinoma syndrome]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:Succinate_dehydrogenase-deficient_tumour_syndromes|Succinate dehydrogenase-deficient tumour syndromes]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:BAP1_tumour_predisposition_syndrome|BAP1 tumour predisposition syndrome]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:Hereditary_phaeochromocytoma-paraganglioma_syndromes|Hereditary phaeochromocytoma-paraganglioma syndromes]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:Tuberous_sclerosis|Tuberous sclerosis]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:Genitourinary_system_and_Lynch_syndrome|Genitourinary system and Lynch syndrome]]
|Disease
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|-
|[[MALE5:Hereditary_tumour_syndromes_associated_with_homologous_recombination_pathway_mutations|Hereditary tumour syndromes associated with homologous recombination pathway mutations]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:Carney_complex|Carney complex]]
|Disease
|
|
|
|
|
|
|
|
|-
|[[MALE5:Peutz-Jeghers_syndrome|Peutz-Jeghers syndrome]]
|Disease
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|-
|-
|}
|}
Retrieved from "https://test.ccga.io/index.php/MALE5:Volunteer_Assignments_and_Opportunities"